Sylvie Ménard

21.5k total citations · 2 hit papers
267 papers, 17.1k citations indexed

About

Sylvie Ménard is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Sylvie Ménard has authored 267 papers receiving a total of 17.1k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Radiology, Nuclear Medicine and Imaging, 122 papers in Molecular Biology and 119 papers in Oncology. Recurrent topics in Sylvie Ménard's work include Monoclonal and Polyclonal Antibodies Research (123 papers), HER2/EGFR in Cancer Research (69 papers) and Glycosylation and Glycoproteins Research (46 papers). Sylvie Ménard is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (123 papers), HER2/EGFR in Cancer Research (69 papers) and Glycosylation and Glycoproteins Research (46 papers). Sylvie Ménard collaborates with scholars based in Italy, United States and Belgium. Sylvie Ménard's co-authors include Elda Tagliabue, Serenella M. Pupa, Manuela Campiglio, Maria I. Colnaghi, Marilena V. Iorio, Patrizia Casalini, Carlo M. Croce, Andrea Balsari, Stefano Volinia and George A. Calin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Sylvie Ménard

263 papers receiving 16.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA Gene Expression Deregulation in Human Breast Cancer

2005 3.3k citations Marilena V. Iorio, Manuela Ferracin et al. Cancer Research profile →
MicroRNA Signatures in Human Ovarian Cancer

2007 1.2k citations Marilena V. Iorio, Rosa Visone et al. Cancer Research profile →

Peers

Countries citing papers authored by Sylvie Ménard

Since Specialization

Citations

This map shows the geographic impact of Sylvie Ménard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Ménard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Ménard more than expected).

Fields of papers citing papers by Sylvie Ménard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Ménard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Ménard. The network helps show where Sylvie Ménard may publish in the future.

Co-authorship network of co-authors of Sylvie Ménard

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Ménard. A scholar is included among the top collaborators of Sylvie Ménard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Ménard. Sylvie Ménard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study 2013 ·Breast Cancer Research and Treatment ·Manuela Campiglio, Rosaria Bufalino, (unknown), Elisa Ferri, Patrizia Casalini, Vincenzo Adamo, Alessandra Fabi, (unknown), Ferdinando Riccardi, Eva M. Martín del Valle, Vieri Scotti, (unknown), Dario Giuffrida, Emiliana Tarenzi, Alessandra Bologna, Giorgio Mustacchi, Francesca Bianchi, Andrea Balsari, Sylvie Ménard, Elda Tagliabue	20
2	TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects 2011 ·Cancer Research ·Michele Sommariva, Loris De Cecco, Michelandrea De Cesare, Lucia Sfondrini, Sylvie Ménard, Cecilia Melani, Domenico Delia, Nadia Zaffaroni, Graziella Pratesi, (unknown), Elda Tagliabue, Andrea Balsari	36
3	microRNA-205 Regulates HER3 in Human Breast Cancer 2009 ·Cancer Research ·Marilena V. Iorio, Patrizia Casalini, Claudia Piovan, Gianpiero Di Leva, Andrea Merlo, Tiziana Triulzi, Sylvie Ménard, Carlo M. Croce, Elda Tagliabue	298
4	MicroRNA Signatures in Human Ovarian Cancer breakdown → 2007 ·Cancer Research ·Marilena V. Iorio, Rosa Visone, Gianpiero Di Leva, Valentina Donati, Fabio Petrocca, Patrizia Casalini, Cristian Taccioli, Stefano Volinia, Chang-Gong Liu, Hansjüerg Alder, George A. Calin, Sylvie Ménard, Carlo M. Croce	1199
5	Regulation of Breast Cancer Response to Chemotherapy by Fibulin-1 2007 ·Cancer Research ·Serenella M. Pupa, (unknown), Fabio Castiglioni, (unknown), Marco Cantù, Italia Bongarzone, Paola Baldassari, Roberta Mortarini, W. Scott Argraves, Andrea Anichini, Sylvie Ménard, Elda Tagliabue	55
6	MicroRNA Gene Expression Deregulation in Human Breast Cancer breakdown → 2005 ·Cancer Research ·Marilena V. Iorio, Manuela Ferracin, Chang‐Gong Liu, Angelo Veronese, Riccardo Spizzo, Silvia Sabbioni, Eros Magri, Massimo Pedriali, Muller Fabbri, Manuela Campiglio, Sylvie Ménard, Juan Palazzo, Anne Rosenberg, Piero Musiani, Stefano Volinia, Italo Nenci, George A. Calin, Patrizia Querzoli, Massimo Negrini, Carlo M. Croce	3320
7	Des enfants sous surveillance : la rééducation des jeunes délinquants au Québec (1840-1950) 2003 ·Sylvie Ménard	5
8	Role of hormonal risk factors in HER2-positive breast carcinomas 2003 ·British Journal of Cancer ·Andrea Balsari, Patrizia Casalini, Rosaria Bufalino, Franco Berrino, Sylvie Ménard	10
9	Absence of the CD1 Molecule Up-Regulates Antitumor Activity Induced by CpG Oligodeoxynucleotides in Mice 2002 ·The Journal of Immunology ·Lucia Sfondrini, Dario Besusso, (unknown), Monica Rodolfo, (unknown), Masaru Taniguchi, Toshinori Nakayama, Mario P. Colombo, Sylvie Ménard, Andrea Balsari	29
10	Nerve Growth Factor Cooperates with p185 in Activating Growth of Human Breast Carcinoma Cells 2000 ·Journal of Biological Chemistry ·Elda Tagliabue, Fabio Castiglioni, Cristina Ghirelli, (unknown), (unknown), Giulia Somenzi, Cecilia Melani, Sylvie Ménard	56
11	Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. 2000 ·PubMed ·Sylvie Ménard, Piera Aiello, Elda Tagliabue, Cristiano Rumio, Pier‐Luigi Lollini, Maria I. Colnaghi, Andrea Balsari	45
12	FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. 1999 ·PubMed ·Manuela Campiglio, Yuri Pekarsky, Sylvie Ménard, Elda Tagliabue, Silvana Pilotti, Carlo M. Croce	92
13	Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line 1999 ·Oncogene ·Serenella M. Pupa, Candace M. Howard, (unknown), R. Vecchi, (unknown), Pier Paolo Claudio, Maria I. Colnaghi, Antonio Giordano, Sylvie Ménard	21
14	Heregulin β1 induces the down regulation and the ubiquitin‐proteasome degradation pathway of p185^HER2 oncoprotein 1998 ·FEBS Letters ·Alessandra Magnifico, Elda Tagliabue, Elena Ardini, Patrizia Casalini, Maria I. Colnaghi, Sylvie Ménard	17
15	Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features 1994 ·British Journal of Cancer ·Sylvie Ménard, Paolo Squicciarini, Alberto Luini, (unknown), Dario Rovini, Elda Tagliabue, Paolo Veronesi, B Salvadori, Umberto Veronesi, Maria I. Colnaghi	44
16	The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage. 1993 ·PubMed ·Serenella M. Pupa, Sylvie Ménard, Daniele Morelli, (unknown), G. De Palo, M. I. Colnaghi	124
17	Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. 1993 ·PubMed ·Serenella M. Pupa, Sylvie Ménard, Salvatore Andreola, M. I. Colnaghi	91
18	Overexpression of p185 is not related to erbB2 amplification in ovarian cancer 1993 ·Annals of Oncology ·(unknown), (unknown), Elda Tagliabue, Manuela Campiglio, Sylvie Ménard, (unknown), Valeria Lucchini, N. Colombo, Costantino Mangioni, L. Redaelli, (unknown)	6
19	Monoclonal Antibodies Against NIH 3T3 Cells Transformed by Human Thyroid Carcinoma DNA 1988 ·Hybridoma ·Rachele Alzani, Marco A. Pierotti, Sylvie Ménard, Silvana Canevari, (unknown), Dario Ballinari, Catia Traversari, Gabriella Della Torre, Paolo Radice, Silvana Pilotti, Alfredo Fusco, Michèle Grieco, Giuseppe Della Porta, Maria I. Colnaghi	1
20	Improvement of Tumor Cell Detection Using a Pool of Monoclonal Antibodies 1986 ·Hybridoma ·Elda Tagliabue, Giuliana Anna Porro, (unknown), Gabriella Della Torre, Sylvie Ménard, Franco Rilke, Serenella Cerasoli, Maria I. Colnaghi	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact